Cancer Drug May Not Get A Chance Due to Lack of Patent
theshowmecanuck writes to mention that in a recent study, researchers at the University of Alberta Department of Medicine have shown that an existing small, relatively non-toxic molecule, dichloroacetate (DCA), causes regression in several different cancers. From the article: "But there's a catch: the drug isn't patented, and pharmaceutical companies may not be interested in funding further research if the treatment won't make them a profit. In findings that 'astounded' the researchers, the molecule known as DCA was shown to shrink lung, breast and brain tumors in both animal and human tissue experiments."
here
-mcgrew (my computer is broken):
Even if the companies do turn it down they will get a further crack at it. Courtesy of the Byah-Dole act most publicly funded research (especially drug research) in the U.S. can later be "bought" by private companies who may then claim "intellectual property" on the fruits of the public's labors. It is this law that allows both AZT and Viagra (developed with funding from the National Institutes of Health) to be considered "private" property and for the companies to charge the people who invested in their development for their use.
The practical upshot of this is that if the drug does go to the universities to be developed it would be following the normal track of most medical research. And if any patentability (say on dosage levels) does show up the companies can always buy it then.
Cuba has a large, thriving and internationally recognized cutting-edge pharmaceutical and biomedical research industry. They specialize in developing and distributing drugs to the 99% of planet Earth that can't afford $5/day to get harder erections. They generally research based on the commonality and severity of particular diseases, and then try to find exceptionally low-cost ways to solve them better. Ironically enough, it's quite profitable since selling tens of millions of pills to entire continents at 1% profit can add up pretty quickly.
Recursive: Adj. See Recursive.
It's not a broken system. On my local news (Edmonton, home of the UofA) they are specifically NOT including drug companies in funding the trials, because they want the drug to be cheap.
FTA:
"A small, non-toxic molecule may soon be available as an inexpensive treatment for many forms of cancer, including lung, breast and brain tumours, say University of Alberta researchers."
Sir Frederick Banting, (another Canadian) did the same thing with his patent for Insulin, so that drug companies would never have a monopoly on something needed for people to live.
"History doesn't repeat itself, but it does rhyme." Mark Twain
Or you can patent one of the production processes for it.
Someone mentioned the inventor of insulin trying to ensure a "no-monopoly" situation, but since the advent of human insulin produced by genetically engineered bacteria (as opposed to from the pancreas of slaughtered cows/pigs), a select few companies (Eli Lilly and Novo Nordisk and that's about it with one exception) have dominated the insulin market since the 1970s (Insulin was discovered in the early 1920s, by the way) due to patents on:
Methods of producing insulin (specifically recombinant DNA origin insulins)
Methods of tweaking insulin to be absorbed/used by the body over a longer period of time by adding stuff to the injected mixture (Lente, Ultralente, NPH, etc)
Methods of producing insulin with "faster than natural" activity profiles by tweaking the molecular structure itself (Humalog and Novolog)
Methods of producing insulin with extremely long "peakless" activity profiles by a combination of the above two techniques (Lantus and Levemir) - BTW this is where the one exception to the Lilly/Nordisk dominance is. Lantus is made by Aventis.
From one "unpatented" drug that according to this article will not have an interest from big pharma, history shows that global market dominance can still be established. I have a feeling drug companies right and left will be racing to tweak this new drug to make a better version or better production process (which happens to be patentable).
retrorocket.o not found, launch anyway?
Actually, if you read the article (I know bizarre), you would have know that it is already and FDA approved drug and is actively prescribed. It has some side effects but nothing horrible. Since it is already approved, getting it cleared for use in a an additional capacity is much easier since it has been proven safe for human use. The only thing that needs to be proved is effecacy.
Sorry my bullshit sensor overloaded.